Acrivon Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	43.42	36.02	29.52	99.6	1.58
Short-Term Investments	144.04	91.44	98.23	-	-
Cash & Short-Term Investments	187.45	127.46	127.75	99.6	1.58
Cash Growth	31.93%	-0.23%	28.26%	6192.04%	-
Prepaid Expenses	1.53	2.23	4.34	0.81	0.14
Total Current Assets	188.98	129.69	132.1	100.41	1.72
Property, Plant & Equipment	8.47	7.91	6.86	5.79	0.06
Long-Term Investments	15.39	-	41.88	-	-
Long-Term Deferred Charges	0.47	0.25	-	-	-
Other Long-Term Assets	1.38	0.41	0.39	0.39	0.41
Total Assets	214.68	138.27	181.23	106.59	2.19
Accounts Payable	1.51	5.05	0.9	0.96	0.14
Accrued Expenses	12.27	7.38	4.14	1.22	0.42
Short-Term Debt	-	-	-	-	0.06
Current Portion of Leases	1.04	0.88	0.73	0.66	-
Current Unearned Revenue	-	-	0.07	0.07	-
Other Current Liabilities	-	-	0.67	-	-
Total Current Liabilities	14.82	13.3	6.52	2.91	0.61
Long-Term Leases	2.97	3.77	4.24	4.96	-
Total Liabilities	17.79	17.07	10.75	7.88	0.61
Common Stock	0.03	0.02	0.02	0	0
Additional Paid-In Capital	370.22	237.68	226.58	1.05	0.21
Retained Earnings	-174.15	-116.42	-56.03	-24.87	-8.62
Comprehensive Income & Other	0.78	-0.08	-0.1	-	-
Total Common Equity	196.89	121.2	170.48	-23.81	-8.41
Shareholders' Equity	196.89	121.2	170.48	98.71	1.57
Total Liabilities & Equity	214.68	138.27	181.23	106.59	2.19
Total Debt	4.01	4.64	4.96	5.63	0.06
Net Cash (Debt)	183.44	122.81	122.79	93.98	1.53
Net Cash Growth	33.25%	0.02%	30.66%	6062.30%	-
Net Cash Per Share	6.15	5.56	29.79	53.90	1.06
Filing Date Shares Outstanding	31.14	22.64	21.92	1.77	1.43
Total Common Shares Outstanding	31.13	22.52	21.92	1.77	1.43
Working Capital	174.17	116.39	125.58	97.49	1.11
Book Value Per Share	6.32	5.38	7.78	-13.45	-5.87
Tangible Book Value	196.89	121.2	170.48	-23.81	-8.41
Tangible Book Value Per Share	6.32	5.38	7.78	-13.45	-5.87
Machinery	6.31	3.13	2.51	0.35	0.08
Construction In Progress	0.02	1.31	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.